Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, U6 small nuclear 412, pseudogene (RNU6-412P)** is a human genomic locus recognized as a pseudogene derived from the U6 small nuclear RNA (snRNA) gene family. U6 snRNA genes encode a non-coding RNA molecule that is integral to the spliceosome and thus plays a crucial role in intron splicing during pre-mRNA processing[1][3][5]. However, pseudogenes like RNU6-412P are characterized by the presence of disabling mutations or truncations that prevent their transcription into a functional RNA or their participation in spliceosome assembly[4]. \n \nPseudogenes can sometimes produce RNA transcripts, and emerging evidence suggests that some pseudogenes may regulate biological processes by acting as decoys for regulatory RNAs or by producing antisense transcripts that interact with related coding genes[2][4]. Nevertheless, the majority of pseudogenes, including RNU6-412P, are not known to encode functional products or serve as conventional therapeutic targets such as receptors, enzymes, or transporters[4]. There is no evidence supporting a role for RNU6-412P in disease, nor are there any drugs known to target or interact with it. In current scientific nomenclature, RNU6-412P is primarily used as a genomic marker or as part of studies on pseudogene evolution and function, rather than as a biomarker or therapeutic target[4].\n\n**Summary**: \nRNU6-412P is a processed pseudogene originating from the U6 small nuclear RNA gene. Unlike its parent gene, it does not encode a functional snRNA or protein and is not considered a receptor, enzyme, or therapeutic target. There are no recognized implications in disease or drug interactions specifically attributed to this locus.
Not applicable; not a protein, enzyme, receptor, or established drug target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 412, pseudogene (RNU6-412P).